Efficacy of Opioids for Chronic Pain: A Review of the Evidence
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Opioid therapy for chronic pain has been popularized over the past few decades, and a concern has arisen that the analgesic efficacy of opioids is not always maintained over prolonged courses of treatment despite dose escalation and stable pain. Considering the potentially serious adverse effects of opioids, the idea that pain relief could diminish over time may have a significant impact on the decision to embark on this therapy, especially in vulnerable individuals. Possible loss of analgesic efficacy is especially concerning, considering that dependence may make it hard to withdraw opioid therapy even in the face of poor analgesia. This article first reviews the evidence on opioid efficacy when used for the treatment of chronic pain, and concludes that existing evidence suggests that analgesic efficacy, although initially good, is not always sustained during continuous and long-term opioid therapy (months to years). The theoretical basis for loss of analgesic efficacy over time is then examined. Mechanisms for loss of analgesic efficacy proposed are pharmacologic tolerance, opioid-induced hyperalgesia, subtle and intermittent withdrawal, and a number of psychologic factors including loss of the placebo component.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
A comparison of observational studies and randomized, controlled trials.
Benson, K., & Hartz, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422506 · Cited by 2,347
Beecher, H. K. (1955) · Journal of the American Medical Association · doi:10.1001/jama.1955.02960340022006 · Cited by 1,842
Robinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
Incentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435
Molecular and Cellular Basis of Addiction
Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,313
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216 · cited 2×
“Reviews of the open-label follow-up studies, however, have shown that up to 56% of patients abandon the treatment because of lack of analgesic efficacy or side effects.(35,36)”
BackgroundOpioid-induced Hyperalgesia: A Qualitative Systematic Review
Angst, M. S., & Clark, J. D. (2006) · Anesthesiology · doi:10.1097/00000542-200603000-00025 · Cited by 1,188
Cited by
Opioid Prescriptions for Chronic Pain and Overdose: A Cohort Study
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta-Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,255
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis
Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015) · Pain · doi:10.1097/01.j.pain.0000460357.01998.f1 · Cited by 1,154
Pharmacological Management of Persistent Pain in Older Persons
(2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00699.x · Cited by 916
Deyo, R. A., Von Korff, M., & Duhrkoop, D. (2015) · BMJ · doi:10.1136/bmj.g6380 · Cited by 507
Hutchinson, M. R., Shavit, Y., Grace, P. M., Rice, K. C., Maier, S. F., & Watkins, L. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004135 · Cited by 397
Deyo, R. A., Hallvik, S. E., Hildebran, C., Marino, M., Dexter, E., Irvine, J. M., O’Kane, N., Van Otterloo, J., Wright, D. A., Leichtling, G., et al. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3810-3 · Cited by 332
“Emergence of drug tolerance and hyperalgesia may limit long-term efficacy.(9) Several factors may explain the emergence of inadvertent longterm use, including opioid dependence, non-medical use, substance use disorders, and diversion to other users.”
BackgroundRogers, A. H., & Farris, S. G. (2022) · European Journal of Pain · doi:10.1002/ejp.1994 · Cited by 280
“Additionally, pain, in general, has been linked to the onset and maintenance of the opioid epidemic (Ballantyne & Shin, 2008; Manchikanti et al., 2012), suggesting that the deleterious outcomes associated with chronic pain are far- reaching.”
BackgroundRelationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain Patients
Saunders, K. W., Dunn, K. M., Merrill, J. O., Sullivan, M., Weisner, C., Braden, J. B., Psaty, B. M., & Von Korff, M. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1218-z · Cited by 271
Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology
Franklin, G. M. (2014) · Neurology · doi:10.1212/wnl.0000000000000839 · Cited by 270
Prescription drug overdoses: A review
Paulozzi, L. J. (2012) · Journal of Safety Research · doi:10.1016/j.jsr.2012.08.009 · Cited by 263
Pain Trends Among American Adults, 2002–2018: Patterns, Disparities, and Correlates
Zajacova, A., Grol-Prokopczyk, H., & Zimmer, Z. (2021) · Demography · doi:10.1215/00703370-8977691 · Cited by 224
A history of being prescribed controlled substances and risk of drug overdose death
Paulozzi, L. J., Kilbourne, E. M., Shah, N. G., Nolte, K. B., Desai, H. A., Landen, M. G., Harvey, W., & Loring, L. D. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01260.x · Cited by 221
Pharmacological treatment of chronic pain—The need for CHANGE
Varrassi, G., Müller-Schwefe, G., Pergolizzi, J., Orónska, A., Morlion, B., Mavrocordatos, P., Margarit, C., Mangas, C., Jaksch, W., Huygen, F., et al. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003689175 · Cited by 167
Must we reduce pain intensity to treat chronic pain?
Sullivan, M. D., & Ballantyne, J. C. (2016) · Pain · doi:10.1097/j.pain.0000000000000336 · Cited by 164
Self-citationThe analgesic potential of cannabinoids.
Elikottil, M., Gupta, M., & Gupta, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0034 · Cited by 141
“In view of these side- effects and the decrease in analgesic efficacy over time [8], there is a need to explore alternative or adjunct medications to opioids in management of severe pain; and cannabinoids are being currently explored as one possible alternative.”
BackgroundGoldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.11.022 · Cited by 102
The Conundrum of Opioid Tapering in Long-Term Opioid Therapy for Chronic Pain: A Commentary
Manhapra, A., Arias, A. J., & Ballantyne, J. C. (2018) · Substance Abuse · doi:10.1080/08897077.2017.1381663 · Cited by 98
Self-citationChronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy
Sehgal, N., Colson, J., & Smith, H. S. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.846517 · Cited by 79
Maguire, D. R., Yang, W., & France, C. P. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204099 · Cited by 71
“…to treat pain is limited by unwanted effects (e.g., constipation, respiratory depression, and nausea), and the use of opioids for extended periods can result in the development of tolerance and physical dependence (Gutstein and Akil, 2005; Ballantyne and Shin, 2008; Manchikanti and Singh, 2008).”
BackgroundBlondell, R. D., Ashrafioun, L., Dambra, C. M., Foschio, E. M., Zielinski, A. L., & Salcedo, D. M. (2010) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3181ba895d · Cited by 59
“Other authors have concluded that pharmacologic tolerance, opioidinduced hyperalgesia, and addiction are associated with treatment failures that may limit the value of long-term opioids (Ballantyne and Shin, 2008).”
BackgroundChronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness
Owen-Smith, A., Stewart, C., Sesay, M. M., Strasser, S. M., Yarborough, B. J., Ahmedani, B., Miller-Matero, L. R., Waring, S. C., Haller, I. V., Waitzfelder, B. E., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-2456-1 · Cited by 54
Trafton, J. A., Sorrell, J. T., Holodniy, M., Pierson, H., Link, P., Combs, A., & Israelski, D. (2012) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-011-9254-y · Cited by 48
Huang, A., Katz, J., & Clarke, H. (2015) · Pain Management · doi:10.2217/pmt.15.7 · Cited by 39
Rogers, A. H., Orr, M. F., Shepherd, J. M., Bakhshaie, J., Ditre, J. W., Buckner, J. D., & Zvolensky, M. J. (2021) · Journal of Behavioral Medicine · doi:10.1007/s10865-020-00169-8 · Cited by 25
Dundas, I., Ravnanger, K., Binder, P.-E., & Stige, S. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.493349 · Cited by 5
Metadata
- Authors
- Ballantyne, J. C., & Shin, N. S.
- Venue
- The Clinical Journal of Pain
- Published
- 2008-07
- Volume
- 24
- Issue
- 6
- Pages
- 469-478
- ISSN
- 0749-8047 (ISSN-L)
- OpenAlex
- W2009383738
- Cited by
- 360
- References
- 122
- FWCI
- 23.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.